Martinsson T, Sjöberg R M, Hallstensson K, Nordling M, Hedborg F, Kogner P
Department of Clinical Genetics, University of Gothenburg, East Hospital, Sweden.
Eur J Cancer. 1997 Oct;33(12):1997-2001. doi: 10.1016/s0959-8049(97)00278-5.
We analysed DNA from 68 neuroblastoma tumours for loss of heterozygosity (LOH) on the distal chromosome 1p (1p-LOH) using PCR-based DNA polymorphisms. Fifteen tumours (22%) displayed 1p-LOH. The shortest region of overlap (SRO) for the deletions was defined proximally by marker D1S244 and distally by marker D1S80. The CDC2L1 locus, located on chromosome 1p36, has been put forward as a neuroblastoma tumour suppressor. We analysed coding regions of the CDC2L1 gene in a subset of aggressive neuroblastoma tumours with known allelic loss for different 1p-markers. Single-stranded conformation polymorphism, heteroduplex and sequencing analysis of tumour DNA did not reveal any significant changes in the coding region. Using a DNA sequence polymorphism, we showed, in a primary tumour with an interstitial allelic deletion, that this tumour had both alleles of the CDC2L1 locus retained in the tumour. Thus, we showed that the neuroblastoma tumour suppressor critical region on 1p in our material is defined by loci D1S244 and D1S80 and that the CDC2L1 locus is distal to the critical region.
我们使用基于聚合酶链反应(PCR)的DNA多态性分析了68例神经母细胞瘤肿瘤的DNA,以检测1号染色体远端(1p)的杂合性缺失(LOH)。15例肿瘤(22%)显示有1p-LOH。缺失的最短重叠区域(SRO)在近端由标记物D1S244界定,在远端由标记物D1S80界定。位于1号染色体1p36的细胞周期蛋白依赖性激酶2样1(CDC2L1)基因座已被提出作为神经母细胞瘤的肿瘤抑制基因。我们分析了一组具有已知不同1p标记等位基因缺失的侵袭性神经母细胞瘤肿瘤中CDC2L1基因的编码区。对肿瘤DNA进行单链构象多态性、异源双链和测序分析,未发现编码区有任何显著变化。利用一个DNA序列多态性,我们在一个具有中间等位基因缺失的原发性肿瘤中发现,该肿瘤中CDC2L1基因座的两个等位基因均保留在肿瘤中。因此,我们表明,在我们的研究材料中,1p上的神经母细胞瘤肿瘤抑制关键区域由基因座D1S244和D1S80界定,且CDC2L1基因座位于关键区域的远端。